SAN FRANCISCO, February 12, 2025--(BUSINESS WIRE)--Homeward ®, a company committed to rearchitecting the delivery of health and care in partnership with communities everywhere, starting in rural ...
- PARADIGM ™ program comprises two 12-week randomized, placebo-controlled studies (APPROACH and EMBRACE) and a long-term extension study (EXTEND) - - EXTEND: a Phase III Open Label Extension Study ...
The innovation startup accelerator "New Paradigm Investment" said on the 12th that it is openly recruiting corporations to join the "2026 Baby Unicorn Growth Program." The application period runs from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results